NCT00332332View on ClinicalTrials.gov

Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

February 28, 2010

Conditions
Psoriasis
Interventions
BIOLOGICAL

etanercept

etanercept subcutaneous injection

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Amgen

INDUSTRY